Samar R El Khoudary1, Saad Samargandy2, Irfan Zeb3, Temitope Foster4, Ian H de Boer5, Dong Li6, Matthew J Budoff7. 1. University of Pittsburgh, Department of Epidemiology, USA. Electronic address: elkhoudarys@edc.pitt.edu. 2. University of Pittsburgh, Department of Epidemiology, USA. 3. West Virginia University Heart & Vascular Institute, Department of Cardiology, USA. 4. Emory University Medical Center, Medicine-Digestive Diseases, USA. 5. University of Washington, Division of Nephrology, USA. 6. Emory University, Division of Hospital Medicine, USA. 7. Los Angeles BioMedical Research Institute, Harbor UCLA Medical Center, USA.
Abstract
BACKGROUND AND AIMS: Low serum 25-hydroxyvitamin D (25(OH)D) is associated with higher nonalcoholic fatty liver disease (NAFLD) risk in studies of mainly white participants. Significant racial/ethnic differences exist in serum 25(OH)D and NAFLD prevalence questioning extending this association to other racial/ethnic groups. We tested whether the association between serum 25(OH)D and NAFLD vary by race/ethnicity. METHODS AND RESULTS: This was a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA) that included 3484 participants (44% male; 38.4% Whites, 27.8% African-Americans, 23.5% Hispanics, and 10.3% Chinese-Americans) who had serum 25(OH)D and upper abdominal CT images available at baseline. Serum 25(OH)D was measured by high-performance liquid chromatography-tandem mass spectrometry. NAFLD was identified if liver-to-spleen Hounsfield-Unit ratio was <1. Whites had the highest 25(OH)D level and African-Americans had the lowest level (mean ± SD: 29.5 ± 10.4 vs.19.9 ± 9.1, respectively). Six hundred and eleven (17.5%) participants had NAFLD; Hispanics had the highest prevalence (26.2%) followed by Chinese-Americans (19.8%), Whites (15.8%) and African-Americans (11.7%), P < 0.0001. In adjusted model, the association of 25(OH)D with NAFLD differed by race/ethnicity (P < 0.0001). Negative association was only evident in Causations (OR (95% CI):1.23 (1.03, 1.47) per 1 SD lower serum 25(OH)D). For other racial/ethnic groups, BMI, triglycerides, diabetic status and/or smoking, but not serum 25(OH)D, were common independent risk factors for NAFLD. CONCLUSIONS: The negative association between serum 25(OH)D and NAFLD in Whites may not be broadly generalizable to other racial/ethnic groups. Modifiable risk factors including BMI, triglycerides, diabetic status and/or smoking associate with NAFLD risk in non-white racial/ethnic groups beyond 25(OH)D.
BACKGROUND AND AIMS: Low serum 25-hydroxyvitamin D (25(OH)D) is associated with higher nonalcoholic fatty liver disease (NAFLD) risk in studies of mainly white participants. Significant racial/ethnic differences exist in serum 25(OH)D and NAFLD prevalence questioning extending this association to other racial/ethnic groups. We tested whether the association between serum 25(OH)D and NAFLD vary by race/ethnicity. METHODS AND RESULTS: This was a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA) that included 3484 participants (44% male; 38.4% Whites, 27.8% African-Americans, 23.5% Hispanics, and 10.3% Chinese-Americans) who had serum 25(OH)D and upper abdominal CT images available at baseline. Serum 25(OH)D was measured by high-performance liquid chromatography-tandem mass spectrometry. NAFLD was identified if liver-to-spleen Hounsfield-Unit ratio was <1. Whites had the highest 25(OH)D level and African-Americans had the lowest level (mean ± SD: 29.5 ± 10.4 vs.19.9 ± 9.1, respectively). Six hundred and eleven (17.5%) participants had NAFLD; Hispanics had the highest prevalence (26.2%) followed by Chinese-Americans (19.8%), Whites (15.8%) and African-Americans (11.7%), P < 0.0001. In adjusted model, the association of 25(OH)D with NAFLD differed by race/ethnicity (P < 0.0001). Negative association was only evident in Causations (OR (95% CI):1.23 (1.03, 1.47) per 1 SD lower serum 25(OH)D). For other racial/ethnic groups, BMI, triglycerides, diabetic status and/or smoking, but not serum 25(OH)D, were common independent risk factors for NAFLD. CONCLUSIONS: The negative association between serum 25(OH)D and NAFLD in Whites may not be broadly generalizable to other racial/ethnic groups. Modifiable risk factors including BMI, triglycerides, diabetic status and/or smoking associate with NAFLD risk in non-white racial/ethnic groups beyond 25(OH)D.
Authors: Claudie Berger; Linda S Greene-Finestone; Lisa Langsetmo; Nancy Kreiger; Lawrence Joseph; Christopher S Kovacs; J Brent Richards; Nick Hidiroglou; Kurtis Sarafin; K Shawn Davison; Jonathan D Adachi; Jacques Brown; David A Hanley; Jerilynn C Prior; David Goltzman Journal: J Bone Miner Res Date: 2012-06 Impact factor: 6.741
Authors: Mahmoud Al Rifai; Michael G Silverman; Khurram Nasir; Matthew J Budoff; Ron Blankstein; Moyses Szklo; Ronit Katz; Roger S Blumenthal; Michael J Blaha Journal: Atherosclerosis Date: 2015-02-07 Impact factor: 5.162
Authors: Anja Beilfuss; Jan-Peter Sowa; Svenja Sydor; Mechthild Beste; Lars P Bechmann; Martin Schlattjan; Wing-Kin Syn; Inga Wedemeyer; Zoltan Mathé; Christoph Jochum; Guido Gerken; Robert K Gieseler; Ali Canbay Journal: Gut Date: 2014-08-18 Impact factor: 23.059
Authors: Christopher D Williams; Joel Stengel; Michael I Asike; Dawn M Torres; Janet Shaw; Maricela Contreras; Cristy L Landt; Stephen A Harrison Journal: Gastroenterology Date: 2010-09-19 Impact factor: 22.682